Integrating DNA sequencing and UPLC-MS/MS analysis, our study presented novel findings that a group of APOC3 SNPs (rs4225, rs4520, rs5128, rs2070666, and rs2070667) exerted global impact on serum lipidomics in NAFLD patients. Here, APOC3 is linked to metabolic dysfunction-associated steatotic liver disease.